BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Hu JF, Wang H, Cui J, Gao S, Hoffman AR, Li W. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget 2017;8:34177-90. [PMID: 27486969 DOI: 10.18632/oncotarget.10918] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Fujita T, Fujii H. New Directions for Epigenetics: Application of Engineered DNA-binding Molecules to Locus-specific Epigenetic Research. Handbook of Epigenetics 2023. [DOI: 10.1016/b978-0-323-91909-8.00020-7] [Reference Citation Analysis]
2 Wen X, Zhang Q, Zhou L, Li Z, Wei X, Yang W, Zhang J, Li H, Xu Z, Cui X, Zhang S, Wang Y, Li W, Hoffman AR, Liu Z, Hu J, Cui J. Intrachromosomal Looping and Histone K27 Methylation Coordinately Regulates the lncRNA H19-Fetal Mitogen IGF2 Imprinting Cluster in the Decidual Microenvironment of Early Pregnancy. Cells 2022;11:3130. [DOI: 10.3390/cells11193130] [Reference Citation Analysis]
3 Yuno M, Nagata S, Fujita T, Fujii H. MSCV-based retroviral plasmids expressing 3xFLAG-Sp-dCas9 for enChIP analysis. Biol Methods Protoc 2021;6:bpab013. [PMID: 34409168 DOI: 10.1093/biomethods/bpab013] [Reference Citation Analysis]
4 Du Z, Wen X, Wang Y, Jia L, Zhang S, Liu Y, Zhou L, Li H, Yang W, Wang C, Chen J, Hao Y, Salgado Figueroa D, Chen H, Li D, Chen N, Celik I, Zhu Y, Yan Z, Fu C, Liu S, Jiao B, Wang Z, Zhang H, Gülsoy G, Luo J, Qin B, Gao S, Kapranov P, Esteban MA, Zhang S, Li W, Ay F, Chen R, Hoffman AR, Cui J, Hu JF. Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network. Genome Biol 2021;22:233. [PMID: 34412677 DOI: 10.1186/s13059-021-02444-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Saifaldeen M, Al-Ansari DE, Ramotar D, Aouida M. Dead Cas9-sgRNA Complex Shelters Vulnerable DNA Restriction Enzyme Sites from Cleavage for Cloning Applications. CRISPR J 2021;4:275-89. [PMID: 33876957 DOI: 10.1089/crispr.2020.0134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Fujita H, Fujita T, Fujii H. Locus-Specific Genomic DNA Purification Using the CRISPR System: Methods and Applications. CRISPR J 2021;4:290-300. [PMID: 33876963 DOI: 10.1089/crispr.2020.0038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Feng H, Song Z. Identification of core miRNAs and regulatory pathways in breast cancer by integrated bioinformatics analysis. Mol Omics 2021;17:277-87. [PMID: 33462573 DOI: 10.1039/d0mo00171f] [Reference Citation Analysis]
8 Oleksiewicz U, Machnik M. Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome. Semin Cancer Biol 2020:S1044-579X(20)30274-1. [PMID: 33359485 DOI: 10.1016/j.semcancer.2020.12.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Moon CI, Tompkins W, Wang Y, Godec A, Zhang X, Pipkorn P, Miller CA, Dehner C, Dahiya S, Hirbe AC. Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. Genes (Basel) 2020;11:E499. [PMID: 32369930 DOI: 10.3390/genes11050499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Holly JMP, Biernacka K, Perks CM. The Neglected Insulin: IGF-II, a Metabolic Regulator with Implications for Diabetes, Obesity, and Cancer. Cells 2019;8:E1207. [PMID: 31590432 DOI: 10.3390/cells8101207] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
11 Zhang S, Wang Y, Jia L, Wen X, Du Z, Wang C, Hao Y, Yu D, Zhou L, Chen N, Chen J, Chen H, Zhang H, Celik I, Gülsoy G, Luo J, Qin B, Cui X, Liu Z, Zhang S, Esteban MA, Ay F, Xu W, Chen R, Li W, Hoffman AR, Hu JF, Cui J. Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing. Genome Res 2019;29:1521-32. [PMID: 31315906 DOI: 10.1101/gr.244996.118] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
12 Fujita T, Fujii H. Purification of specific DNA species using the CRISPR system. Biol Methods Protoc 2019;4:bpz008. [PMID: 32395626 DOI: 10.1093/biomethods/bpz008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Xu X, Qi LS. A CRISPR–dCas Toolbox for Genetic Engineering and Synthetic Biology. Journal of Molecular Biology 2019;431:34-47. [DOI: 10.1016/j.jmb.2018.06.037] [Cited by in Crossref: 163] [Cited by in F6Publishing: 177] [Article Influence: 54.3] [Reference Citation Analysis]
14 Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, Jia L, Zhou L, Li W, Hoffman AR, Hu JF, Cui J. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol 2018;19:218. [PMID: 30537986 DOI: 10.1186/s13059-018-1594-y] [Cited by in Crossref: 182] [Cited by in F6Publishing: 203] [Article Influence: 45.5] [Reference Citation Analysis]
15 Liu H, Lei C, He Q, Pan Z, Xiao D, Tao Y. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer 2018;17:64. [PMID: 29471827 DOI: 10.1186/s12943-018-0765-5] [Cited by in Crossref: 168] [Cited by in F6Publishing: 180] [Article Influence: 42.0] [Reference Citation Analysis]
16 Wang H, Guo R, Du Z, Bai L, Li L, Cui J, Li W, Hoffman AR, Hu JF. Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors. Mol Ther Nucleic Acids. 2018;11:23-33. [PMID: 29858058 DOI: 10.1016/j.omtn.2018.01.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
17 Küffer S, Gutting T, Belharazem D, Sauer C, Michel MS, Marx A, Trojan L, Ströbel P. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation. Mol Oncol 2018;12:256-66. [PMID: 29239100 DOI: 10.1002/1878-0261.12164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Fujita T, Kitaura F, Yuno M, Suzuki Y, Sugano S, Fujii H. Locus-specific ChIP combined with NGS analysis reveals genomic regulatory regions that physically interact with the Pax5 promoter in a chicken B cell line. DNA Res 2017;24:537-48. [PMID: 28586432 DOI: 10.1093/dnares/dsx023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
19 Salvianti F, Canu L, Poli G, Armignacco R, Scatena C, Cantini G, Di Franco A, Gelmini S, Ercolino T, Pazzagli M, Nesi G, Mannelli M, Pinzani P, Luconi M. New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer. Oncotarget 2017;8:65525-33. [PMID: 29029450 DOI: 10.18632/oncotarget.19118] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
20 Powell SK, Gregory J, Akbarian S, Brennand KJ. Application of CRISPR/Cas9 to the study of brain development and neuropsychiatric disease. Mol Cell Neurosci 2017;82:157-66. [PMID: 28549865 DOI: 10.1016/j.mcn.2017.05.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]